Safety and Tolerability Study for T-1301 Capsules to Treat Advanced Solid Tumors

NCT05156203 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor
Lymphoma

Interventions

DRUG: T-1301 Capsules

Sponsor

Taivex Therapeutics Corporation